June 30, 2025 — Within a month, we expect that U.S. Dietary Guidelines will come out of the MAHA machine, looking like nothing that came before. Speculation is rife and the expectations are low that this new incarnation will be tethered to nutrition research. Writing in The Atlantic about HHS Secretary Robert Kennedy Jr. and the imminent issuance of […]
June 29, 2025 — It is jarring to hear much talk about making America great while we see signs that American biotech leadership is fading. Until now, America has been the unquestioned leader in biotechnology innovation. But hard data suggests that China is chipping away at that. Recent actions by the U.S. federal government seem to be opening the […]
June 28, 2025 — People living with obesity face a heavy and often hidden burden – financial, physical, social, and psychological – embedded in health systems and extending far beyond health risks. A nationally representative U.S. study reveals that one in six adults with obesity struggles to afford healthcare, routinely skipping medications or even meals to manage cost. With […]
June 27, 2025 — Let’s start with a few basics. Expensive bunk is not a substitute for actual healthcare. And glucose monitoring (in the absence of diabetes) is no substitute for obesity medicine. Not even close. Unfortunately right now, the latest DIY fashion for ineffectively dealing with obesity is self-monitoring – for its own sake. Not for the sake […]
June 26, 2025 — Stepping back from the intense swirl of obesity care research at the ADA meeting just concluded, one thing stands out: People are having a very hard time following the thread of all this innovation. If you have any doubt, just scan the reports of investment analysts at the meeting. On one hand, they know they […]
June 25, 2025 — For the last 18 months, some of the smartest people we know in the realm of obesity policy have been busy drawing a map. Their map, announced today, shows the way for transforming obesity care through three solution areas. These include creating engagement, building capabilities, and delivering integrated care. It comes from the Center for […]
June 24, 2025 — On the closing day of the ADA Scientific Sessions in Chicago, we got a good look at two remarkable new obesity drugs. Both of them have potential to bring important advances. Both of them need more work before they will be ready to go to FDA for approval. This was a rare treat. Bimagrumab The […]
June 23, 2025 — With two new publications in the New England Journal of Medicine, we are thinking that CagriSema has something to teach us about using weight loss outcomes to judge the merits of a new obesity medicine. Is more always better? Researchers presented the data from these two pivotal clinical trials on CagriSema at the ADA Scientific […]
June 22, 2025 — We are only halfway through ADA2025 in Chicago and already the flood of information about new drugs for obesity like orforglipron, amycretin, and a host of others leaves us feeling like we have been sprayed down by a fire hose. Much more will be coming at us in the next two days. Orforglipron and Other […]
June 21, 2025 — “It takes a village to create standards of care,” said Nuha Ali El Sayed as she opened a symposium on the emerging standards of care for obesity. Truer words were never spoken. Defining these standards is tricky. That’s because they they need to reflect both what is desirable and a standard that good health professionals […]
